B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

RARA

MOLECULAR TARGET

retinoic acid receptor alpha

UniProt: P10276NCBI Gene: 5914135 compounds

RARA (retinoic acid receptor alpha) is targeted by 135 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting RARA

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Disulfiram2.087
2Progesterone1.956
3cycloheximide1.956
4Adapalene1.795
5Hexachlorophene1.795
6Astemizole Antihistamine drug now withdrawn from1.614
7Azacitidine1.614
8Azacitidine1.614
9Celecoxib1.614
10Dactinomycin1.614
11Danazol1.614
12Dinitrochlorobenzene1.614
13Ethidium1.614
14Norethindrone1.614
15Oxymetholone1.614
16Promethazine1.614
17Budesonide1.393
18Genistein1.393
19Vitamin1.393
2017 alpha-Hydroxyprogesterone Caproate Hydroxyprogesterone derivative that acts as1.393
21Chlorhexidine1.393
22Clotrimazole1.393
23Desoxycorticosterone1.393
24Levonorgestrel1.393
25Nisoldipine1.393
26Norgestrel1.393
27Rotenone1.393
28Thiabendazole 2-Substituted benzimidazole first introduced in 1962. It is active against1.393
29Troglitazone1.393
30Pueraria1.102
31Methylene Blue1.102
32Resveratrol1.102
33Testosterone1.102
34Aprepitant1.102
35Betamethasone Valerate1.102
36candesartan cilexetil [Supplementary Concept]1.102
37Chlormadinone Acetate1.102
38Colchicine1.102
39Dasatinib1.102
40Daunorubicin1.102
41dilazep1.102
42Dimethisterone1.102
43Emetine1.102
44Estriol1.102
45Estrone1.102
46Ethoxyquin Antioxidant; also1.102
47Fluspirilene1.102
48Flutamide1.102
49Gemfibrozil1.102
50Gestrinone1.102

Showing top 50 of 135 compounds. Use the BiohacksAI search to explore all RARA modulators.

About RARA as a Drug Target

RARA (retinoic acid receptor alpha) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 135 compounds with documented RARA interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

RARA inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.